Imperial Oil Limited Common Stock (IMO)

Total Liabilities

$23.32B

Quarterly · Period ending: · CAD

IMO logo

IMO Total Liabilities

Latest reported$23.32B CAD
IMO Quarterly Total Liabilities · CAD ($4.16B → $23.32B)
High-resolution chart · PNG

IMO total liabilities history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Imperial Oil Limited Common Stock Total Liabilities — Quarterly (CAD)
Period endingTotal Liabilities (CAD)
23,320,000,000
22,705,000,000
20,055,000,000
19,306,302,000
19,179,000,000
19,478,000,000
19,465,000,000
18,890,000,000
20,199,000,000
19,401,000,000
18,977,000,000
19,778,000,000
18,298,000,000
18,680,000,000
21,111,000,000
20,678,000,000
22,913,000,000
21,534,000,000
19,047,000,000
19,666,000,000
18,170,000,000
17,271,000,000
16,613,000,000
16,590,000,000
16,584,000,000
16,843,000,000
17,911,000,000
16,942,000,000
16,907,000,000
18,178,000,000
16,967,000,000
17,840,000,000
17,625,000,000
16,996,000,000
17,166,000,000
16,349,000,000
16,105,000,000
16,106,000,000
16,633,000,000
18,112,000,000
20,172,000,000
19,839,000,000
19,745,000,000
20,291,000,000
20,075,000,000
18,901,000,000
18,300,000,000
17,863,000,000
17,879,000,000
18,384,000,000
17,694,000,000
18,185,000,000
17,676,000,000
16,096,000,000
12,987,000,000
12,819,000,000
12,577,000,000
12,391,000,000
12,108,000,000
11,031,000,000
10,602,000,000
10,244,000,000
9,403,000,000
8,652,000,000
7,975,000,000
8,392,000,000
8,034,000,000
7,412,000,000
7,739,000,000
7,628,000,000
7,969,888,295
9,577,000,000
10,008,027,000
8,849,912,560
8,363,293,276
9,528,967,505
9,379,384,000
9,106,319,000
8,734,855,545
8,657,651,000
8,275,515,895
8,380,429,706
8,948,714,967
8,833,914,053
7,881,428,747
7,674,727,932
7,704,584,000
7,302,507,245
6,733,822,548
6,745,802,728
6,583,794,925
6,668,017,288
6,868,836,958
7,094,167,768
6,655,649,984
6,484,127,000
6,544,931,050
6,384,639,898
6,332,378,223
6,916,522,014
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.